Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by patients with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 4, Issue 1, 2005, Pages 49-52

  Nadesalingam, Kavitha ^a   Conway, Steven P ^b   Denton, Miles ^b,c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Cystic fibrosis; Methicillin resistant; Risk factors; Staphylococcus aureus

Indexed keywords

AMOXICILLIN; CEPHALOSPORIN; CIPROFLOXACIN; COLISTIN; FLUCLOXACILLIN; MACROLIDE;

ADOLESCENT; ADULT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BACTERIUM ISOLATION; CHILD; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; ERADICATION THERAPY; FEMALE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFANT; INFECTION CONTROL; INFECTION RISK; LENGTH OF STAY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; RETROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; SCORING SYSTEM; STAPHYLOCOCCUS INFECTION;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CIPROFLOXACIN; CYSTIC FIBROSIS; FEMALE; HUMANS; LENGTH OF STAY; MALE; METHICILLIN; METHICILLIN RESISTANCE; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 14844293848     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2004.09.002     Document Type: Article

References (25)

1. M.P. Jevons Celbenin-resistant staphylococci BMJ 1 1961 124-125
2. W.B. Grubb Genetics of MRSA Rev. Med. Microbiol. 9 1998 153-162
3. L.A. Herwaldt Control of methicillin resistant Staphylococcus aureus in the hospital setting Am. J. Med. 106 1999 11-18
4. N.S. Crowcroft O. Ronveaux D.L. Monnet R. Mertens Methicillin resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals Infect. Control Hosp. Epidemiol. 20 1999 31-36
5. E.M. Graffunder R.A. Venezia Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials J. Antimicrob. Chemother. 49 2002 999-1005
6. M. Tumbarello K. de Gaetano Donati E. Tacconelli R. Citton T. Spanu F. Leone, et al. Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients J. Antimicrob. Chemother. 50 2002 375-382
7. A. Voss D. Milatovic C. Wallrauch-Schwarz V.T. Rosdahl L. Braveny Methicillin-resistant Staphylococcus aureus in Europe Eur. J. Clin. Microbiol. Infect. Dis. 13 1994 50-55
8. A.S. Haddadin S.A. Fappiano P.A. Lipsett Methicillin-resistant Staphylococcus aureus (MRSA) in the intensive care unit Postgrad Med. J. 78 2002 385-392
9. H. Von Baum C. Schmidt D. Svoboda O. Bock-Hensley C. Wendt Risk factors for methicillin-resistant Staphylococcus aureus carriage in residents of German nursing homes Infect. Control Hosp. Epidemiol. 23 2002 511-515
10. The Hôpital Propre II Study Group Methicillin-resistant Staphylococcus aureus in French hospitals: A 2-month survey in 43 hospitals, 1995 Infect. Control Hosp. Epidemiol. 20 1999 478-486
11. G. Dziekan A. Hahn K. Thune G. Schwarzer K. Schafer F.D. Daschner Methicillin resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study J. Hosp. Infect. 46 2000 263-270
12. B. Boxerbaum M.R. Jacobs R.L. Cechner Prevalence and significance of methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis Pediatr. Pulmonol. 4 1988 159-163
13. C. Branger J.M. Fournier J. Loulergue Epidemiology of Staphylococcus aureus in patients with cystic fibrosis Epidemiol. Infect. 112 1994 489-500
14. S.R. Thomas K.M. Gyi H. Gaya M.E. Hodson Methicillin-resistant Staphylococcus aureus - impact at a national cystic fibrosis centre J. Hosp. Infect. 40 1998 203-209
15. L.S. Miall N.T. McGinley K.G. Brownlee S.P. Conway Methicillin resistant Staphylococcus aureus (MRSA) infection in cystic fibrosis Arch. Dis. Child. 84 2001 160-162
16. A. Solis D. Brown J. Hughes H.K. VanSaene D.P. Heaf Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: An eradication protocol Pediatr. Pulmonol. 36 2003 189-195
17. L.A. Garske T.J. Kidd R. Gan J.P. Bunting C.A. Franks C. Coulter, et al. Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection J. Hosp. Infect. 56 2004 208-214
18. T.W.R. Lee K.G. Brownlee S.P. Conway M. Denton J.M. Littlewood Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis J. Cystic Fibros. 2 2003 29-34
19. S. Stefani P.E. Varaldo Epidemiology of methicillin-resistant staphylococci in Europe Clin. Microbiol. Infect. 9 2003 1179-1186
20. Working Party Report Revised guidelines for the control of MRSA infection in hospitals J. Hosp. Infect. 39 1998 253-280
21. N. Hoiby J.O. Jarlov M. Kemp M. Tvede J.M. Bangsborg A. Kjerulf, et al. Excretion of ciprofloxacin in sweat and multi-resistant Staphylococcus epidermidis Lancet 349 1997 167-169
22. N. Hoiby C. Pers H.K. Johansen H. Hansen and Copenhagen Study Group on Antibiotics in Sweat Excretion of Β-lactam antibiotics in sweat - A neglected mechanism for the development of antibiotic resistance? Antimicrob. Agents Chemother. 44 2000 2855-2857
23. M. Denton K.G. Kerr N.J. Todd J.M. Littlewood Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients Eur. J. Clin. Microbiol. Infect. Dis. 15 1996 402-405
24. E.J. Simmonds J.M. Littlewood V. Hopwood E.G. Evans Aspergillus fumigatus colonisation and population density of place of residence in cystic fibrosis Arch. Dis. Child. 70 1994 139-140
25. H.R. Stutman J.M. Lieberman E. Nussbaum M.I. Marks Antibiotic prophylaxis in infants and young children with cystic fibrosis: A randomized controlled trial J. Pediatr. 140 2002 299-305